Kühn S, Gallinat J (2011): Quantitative meta-analysis on state and trait aspects of auditory verbal hallucinations in schizophrenia. Schiziphrenia Bull (in Druck)

Kühn S, Schubert F, Gallinat J (2010): Reduced thickness in medial orbitofrontal cortex in smokers. Biol Psychiatry 68: 1061-1065

Spanagel R, Bartsch D, Brors B, Dahmen N, Deussing J, Eils R, Ende G, Gallinat J, Gebicke-Haerter P, Heinz A, Kiefer F, Jäger W, Mann K, Matthäus F, Nöthen M, Rietschel M, Sartorius A, Schütz G, Sommer WH, Sprengel R, Walter H, Wichmann E, Wienker T, Wurst W, Zimmer A. (2010): An integrated genome research network for studying the genetics of alcohol addiction. Addict Biol 15: 369-379.

Gallinat J, Heinz A (eds.): Facharztbuch Psychiatrie, Elsevier, München (2010)

Hauser M, Moore JW, de Millas W, Gallinat J, Heinz A, Haggard P, Voss M (2010): Sense of agency is altered in patients with a putative psychotic prodrome. Schizophrenia Res (in Druck)

Winterer G, Mittelstrass K, Giegling I, Lamina C, Fehr C, Brenner H, Breitling LP, Nitz B, Raum E, Müller H, Gallinat J, Gal A, Heim K, Prokisch H, Meitinger T, Hartmann AM, Möller HJ, Gieger C, Wichmann HE, Illig T, Dahmen N, Rujescu D (2010): Risk gene variants for nicotine dependence in the CHRNA5-CHRNA3-CHRNB4 cluster are associated with cognitive performance. Am J Med Genet B Neuropsychiatr Genet (in Druck)

Hauser M, Knoblich G, Repp B, Lautenschlager M, Gallinat J, Heinz A, Voss M (2010): Altered sense of agency in schizophrenia and the putative psychotic prodrome. Psychiatry Res (in Druck)

Voss M, Moore J, Hauser M, Gallinat J, Heinz A, Haggard P (2010): Altered awareness of action in schizophrenia: a specific deficit in predicting action consequences. Brain 133:3104-3112

Mobascher A, Brinkmeyer J, Warbrick T, Wels C, Wagner M, Gründer G, Spreckelmeyer KN, Wienker T, Lacava AD, Dahmen N, Böttcher M, Thuerauf N, Clepce M, Kiefer F, De Millas W, Gallinat J, Winterer G (2010): The P300 event-related potential and smoking - a population-based case-control study. Int J Psychophysiol 77: 166-175

Klär AA, Ballmaier M, Leopold K, Häke I, Schaefer M,Brühl R, Schubert F, Gallinat J (2010): Interaction of hippocampal volume and N-acetylaspartate concentration deficits in schizophrenia: A combined MRI  and 1H-MRS study. Neuroimage 53: 51-57

Mobascher A, Rujescu D, Mittelstrass K, Giegling I, Lamina C, Nitz B, Brenner H, Fehr C, Breitling LP, Gallinat J, Rothenbacher D, Raum E, Müller H, Ruppert A, Hartmann AM, Möller HJ, Gal A, Gieger Ch, Wichmann HE, Illig T, Dahmen N, Winterer G (2010): Association of a variant in the muscarinic acetylcholine receptor 2 gene (CHRM2) with nicotine addiction. Am J Med Genet B Neuropsychiatr Genet 153B(2): 684-690

Westhoff TH, Schubert F, Wirth C, Joppke M, Klär AA, Zidek W, Gallinat J (2010): The impact of blood pressure on hippocampal glutamate and mnestic function. J Hum Hypertens (in Druck)

Stadelmann A, Roser P, Arning L, Gallinat J, Epplen JT, Juckel G (2010): Akute effects of ?9-tetrahydrocannabinal on the auditory evoked mismatch negativity are modulated by the NRG1 gene. Pharmacopsychiatry 43: 194-195

Schlagenhauf J, Dinges M, Beck A, Wüstenberg T, Friedel E, Dembler T, Sarkar, R, Wrase J, Gallinat J, Juckel G,Heinz A (2010): Switching schizophrenia patients from typical neuroleptics to aripiprazole: effects on working memory dependent functional activation. Schizophrenia Res 118: 189-200

Hurlemann R, Patin A, Onur OA, Cohen M, Baumgartner T, Metzler S, Dziobek I, Gallinat J, Wagner M, Maier W, Kendrick KM (2010): Oxytocin enhances amygdala-dependent, socially reinforced learning and emotional empathy in humans. J Neurosci 30: 4999-5007

Schumann G, Loth E, Banaschewski T, Barbot A, Barker GJ, Büchel C, Conrod PJ, Dalley JW, Flor H, Gallinat J, Garavan H, Heinz A, Ittermann B, Lathrop M, Mallik CA, Mann K, Martinot JL, Paus T, Poline JB, Robbins TW, Rietschel M, Reed L, Smolka MN, Spanagel R, Speiser C, Stephens DN, Ströhle A, Struve M, and the IMAGEN consortium (2010): The IMAGEN study: Reinforcement-related behaviour in normal brain function and psychopathology Mol Psychiatry

Montag C, Dziobek I, Richter IS, Neuhaus K, Lehmann A, Sylla R, Heekeren HR, Heinz A, Gallinat J (2010): Differentiating theory of mind in paranoid schizophrenia: an evidence from a video-based assessment. Psychiatry Res (in Druck)

Reese J, Kraschewski A, Anghelescu I, Winterer G, Schmidt LG, Gallinat J, Rüschendorf F, Rommelspacher H, Wernicke C (2010): Haplotypes of dopamine and serotonin transporter genes are associated with antisocial personality disorder in alcoholics. Psychiat Genet 20: 140-152

Budde H, Sander T, Wernicke C, Müller A, Gallinat J, Schmidt LG, Smolka MN (2010) Serotonin transporter promoter polymorphism and dopaminergic sensitivity in alcoholics. J Neural Transm 117(1): 133-138

Hoffmann AOM, Lee AH, Wertenauer F, Ricken R, Jansen JJ, Gallinat J, Lang UE (2010): Dog assisted activities significantly reduce anxiety in hospitalized patients with major depression Eur J Integra Med (in Druck)

Montag C, Ehrlich A, Neuhaus K, Dziobek I, Heekeren HR, Heinz A, Gallinat J (2010): Theory of mind impairments in euthymic bipolar patients J Affect Disord 123(1-3): 264-269 

Ströhle A, Stoy M, Graetz B, Gallinat J, Lang UE, Dimeo F, Hellweg R (2010): Acute exercise ameliorates reduced brain-derived neurotrophic factor in patients with panic disorder. Psychoneuroendocrinology 35: 364-368

Kraschewski A, Reese J, Anghelescu I, Winterer G, Schmidt LG, Gallinat J, Finckh U, Rommelspacher H, Wernicke C (2009). Association of the dopamine D2 receptor gene will alcohol dependence: haplotypes and subgroups of alcoholics as key factors for understanding receptor function. Pharmacogenet Genomics  19(7): 513-527.

Heinz A, Beck A, Wrase J, Mohr J, Obermayer K, Gallinat J, Puls I (2009) Neurotransmitter systems inalcohol dependence. Pharmacopsychiatry 42: 95-101

Breitling LP, Dahmen N, Mittelstraß K, Rujescu D, Gallinat J, Fehr C, Giegling I, Lamina C, Illig T, Müller H, Raum E, Rothenbacher D, Wichmann HE, Brenner H, Winterer G.(2009): Association of nicotinic acetylcholine receptor subunit alpha4 polymorphisms with nicotine dependence in 5500 Germans. Pharmacogenomics J 9: 219-224

Gudlowski Y, Özgürdal S, Witthaus H, Gallinat J, Hauser M, Winter C, Uhl I, Heinz A, Juckel G (2009): Serotonergic dysfunction in the prodromal, first-episode and chronic course of schizophrenia as assessed by the loudness dependence of auditory evoked activity Schizophrenia Res 109(1-3): 141-147

Gallinat J, Schubert F, Brühl R, Hellweg R, Klär AA, Sander T, Lang UE (2009): Met carriers of BDNF Val66Met genotype show increased N-acetylaspartate concentration in the anterior cingulate cortex. Neuroimage 49(1):767-71

Müller DJ, Peter C, Puls I, Brandl EJ, Lang UE, Gallinat J, Heinz A (2009): Genetics of weight gain associated with antipsychotic medications. Nervenarzt 80(5): 556-563

Lang UE, Hartmann S, Schulz-Hartmann S, Neuhaus K, Gudlowski Y, Munk I, von Haebler D, Gallinat J, Heinz A (2009): Are closed doors really a savety factor? J Psychiat Ment Health Nurs (in Druck)

Roser P, Gallinat J, Weinberg G, Juckel G, Gorynia I, Stadelmann AM (2009): Psychomotor performance in relation to acute oral administration of ?9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects. Eur Arch Psych Clin N 259(5):284-92

Schlagenhauf F, Sterzer P, Schmack K, Ballmaier M, Rapp M, Wrase J, Juckel G, Gallinat J, Heinz A (2009): Reward feedback alterations in unmedicated schizophrenia patients: relevance for delusions. Biol Psychiatry 65(12):1032-1039

Lang U, Hellweg R, Sander T, Gallinat J (2009) The met allele of the BDNF val66met polymorphism is associated with increased BDNF serum concentrations. Mol Psychiatry 14: 120-122

Witthaus H, Kaufmann C, Bohner G, Özgürdal S, Gudlowski Y, Gallinat J, Ruhrmann S, Brüne M, Heinz A, Klingebiel, Juckel G (2009): Gray matter abnormalities in subjects at ultra-high risk for schizophrenia and first-episode schizophrenic patients compared to healthy controls Psychiatr Res: Neuroimaging 173(3):163-9

Wernicke C, Reese J, Kraschewski A, Winterer G, Rommelspacher H, Gallinat J (2009): Distinct haplogenotypes of the dopamine D2 receptor gene are associated with non-smoking behaviour and daily cigarette consumption. Pharmacopsychiatry 42: 41-50

Ballmaier M, Schlagenhauf F, Toga AW, Gallinat J, Koslowski M, Zoli M, Hojatkashani C, Narr KL, Heinz A. (2008) Regional patterns and clinical correlates of basal ganglia morphology in non-medicated schizophrenia. Schizophr Res 106(2-3): 140-147

Gudlowski Y, Gallinat J (2008): Die Glutamathypothese der Schizophrenie Nervenheilkunde 27: 317-325

Schlagenhauf F, Wüstenberg T, Schmack K, Dinges M, Wrase J, Koslowski M, Kienast T, Bauer M, Gallinat J, Juckel G, Heinz A (2008): Switching schizophrenia patients from typical neuroleptics to olanzapine: Effects on BOLD response during attention and working memory Eur Neuropsychopharmacol 18(8): 589-599

Tretter F, Gallinat J, Müller WE (2008): Systems biology and psychiatry: the functional architecture of molecular networks in mental disorders - data and models. Editorial. Pharmacopsychiatry 41 Suppl 1: S1

Schmack K, Schlagenhauf F, Sterzer P, Wrase J, Beck A, Dembler T, Kalus P, Puls I, Sander T, Heinz A, Gallinat J (2008): Catechol-O-methyltransferase val158met genotype influences neural processing of reward anticipation. Neuroimage 42(4): 1631-1638

Gallinat J, Bauer M, Heinz A (2008): Genes and Neuroimaging: Advances in psychiatric research. Neurodegener Dis 5: 277-285

Rentzsch J, Gomez Carrillo de Castro A, Neuhaus A, Jockers-Scherübl M, Gallinat J (2008) Comparison of midlatency auditory sensory gating at short and long interstimulus intervals. Neuropsychobiology 58: 11-18

Özgürdal S, Gudlowski Y, Witthaus H, Hauser M, Gorynia I, Gallinat J, Heinze M, Heinz A, Juckel G (2008): Reduction of auditory event-related P300 amplitude in subjects of at-risk mental state for schizophrenia. Schizophr Res105(1-3): 272-278.

Roser P, Juckel G, Rentzsch J, Nadulski T, Stadelmann AM, Gallinat J* (2008): Effects of acute oral delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers. Eur Neuropsychopharmacol 18(8):569-577 *(shared last authorship)

Gallinat J (2008): Nicotine dependence. Encyclopedia of Molecular Mechanisms of Disease. Lang F (Ed.), Springer, New York

Puls I, Gallinat J (2008): The concept of endophenotypes in psychiatric diseases. Meeting the expectations? Pharmacopsychiatry Suppl 1: S37-43

Lang UE, Hellweg R, Bajbouj M, Gaus V, Sander T, Gallinat J (2008): Gender dependent association of a functional NGF polymorphism with anxiety-related personality traits. Pharmacopsychiatry 41(5):196-919

Montag C, Gallinat J, Heinz A (2008): Theodor Lipps and the concept of empathy 1851-1914. Am J Psychiatry 165(10): 1261

Montag C, Schubert F, Heinz A, Gallinat J (2008): Prefrontal cortex glutamate correlates with mental perspective taking. PLoS ONE 3(12): e3890

Lohoff FW, Lautenschlager M, Mohr J, Ferraro TN, Sander T, Gallinat J (2008): Association between variation in the vesicular monoamine transporter 1 gene on chromosome 8p and anxiety-related personality traits. Neurosci Lett 434(1): 41-45

Müller DJ, Mandelli L, Serretti A, DeYoung CG, De Luca V, Sicari T, Tharmalingam S, Gallinat J, Muglia P, De Ronchi D, Jain U, Kennedy JL (2008): The serotonin transporter gene interacts with adverse life events in adult ADHD. Am J Med Gen B 147B(8):1461-1469

Frey A, Lampert A, Gallinat J, Lang F, Lang UE (2008): Thyrotropin serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychobiology 56(2-3):123-126

Juckel G, Gudlowski Y, Müller D, Ozgürdal S, Brüne M, Gallinat J, Frodl T, Witthaus H, Uhl I, Wutzler A, Pogarell O, Mulert C, Hegerl U, Meisenzahl EM (2007): Loudness dependence of the auditory evoked N1/P2 component as an indicator of serotonergic dysfunction in patients with schizophrenia - A replication study. Psychiatry Res 158(1): 79-82

Schlagenhauf F, Juckel G, Koslowski M, Kahnt K, Knutson B, Dembler T, Kienast T, Gallinat J, Wrase J, Heinz A (2007): Reward system activation in schizophrenic patients switched from typical neuroleptics to olanzapine. Psychopharmacology 196(4): 673-84

Lang U, Puls I, Müller D, Strutz-Seebohm N, Gallinat J (2007) Molecular mechanisms of schizophrenia. Cell Physiol Biochem 20: 687-702

Gallinat J, Obermayer K, Heinz A (2007): Systems neurobiology of the dysfunctional brain: schizophrenia. Pharmacopsychiatry Suppl. 1: S40-44

Juckel G, Roser P, Nadulski T, Stadelmann AM, Gallinat J (2007): Acute effects of ?9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity. Schizophr Res 97: 109-117

Rentzsch J, Jockers-Scherübl MC, Boutros NN, Gallinat J (2007): Test-retest reliability of P50, N100 and P200 auditory sensory gating in healthy subjects. Int J Psychophysiol 67(2): 81-90

Lang UE, Hellweg R, Gallinat J, Bajbouj M (2007): Acute prefrontal cortex transcranial magnetic stimulation in healthy volunteers: No effects on brain-derived neurotrophic factor (BDNF) concentrations in serum J Affect Disord 107: 1-3

Gallinat J, Müller DJ, Bierbrauer J, Rommelspacher H, Juckel G, Wernicke C (2007): Functional cortical effects of novel allelic variants of the serotonin transporter gene linked polymorphic region (5-HTTLPR) in humans Pharmacopsychiatry 40:191-195

Winterer G, Musso F, Konrad A, Vucurevic G, Stoeter P, Sander T, Gallinat J (2007): Association of attentional network function with exon 5 variations of the CHRNA4 gene Hum Mol Genet 16(18):2165-2174

Rentzsch J, Penzhorn A, Kernbichler K, Plöckl D, Gómez-Carrillo de Castro A, Gallinat J, Jockers-Scherübl MC (2007): Differential impact of heavy cannabis use on sensory gating in schizophrenic patients and otherwise healthy controls. Exp Neurol 205(1): 241-249

Fuerst DR, Gallinat J, Boutros NN (2007): Range of Sensory Gating Values and Test-Retest Reliability in Normal Subjects. Psychophysiology 44(4): 620-626

Montag C, Heinz A, Kunz D, Gallinat J (2007): Self-reported empathic abilities in schizophrenia. Schizophr Res 92(1-3): 85-89

Gallinat J, Schubert F (2007): Regional cerebral glutamate concentrations and chronic tobacco consumption. Pharmacopsychiatry 40(2): 64-67

Juckel G, Hegerl U, Giegling I, Mavrogiorgou P, Gallinat J, Augustin H, Mulert C, Pogarell O, Rujescu D (2007) Loudness dependence of auditory evoked potentials is not associated with polymorphisms or haplotypes in the serotonin transporter gene in a community-based sample of German healthy volunteers Psychiatry Res 153(2):183-187

Lang UE, Hellweg R, Seifert F, Schubert F, Gallinat J (2007): Correlation between serum BDNF levels and in vivo markers of cortical integrity. Biol Psychiatry 62(5):530-5

Lang UE, Sander T, Lohoff F, Hellweg R, Bajbouj M, Winterer G, Gallinat J (2007): Association of the met66 allele of brain-derived neurotrophic factor (BDNF) with smoking Psychopharmacology 190(4): 433-439

Lang UE, Bajbouj M, Sander T, Winterer G, Gallinat J (2007): Gender-dependent association of the functional catechol-O-methyltransferase Val158Met genotype with sensation seeking personality trait Neuropsychopharmacology 32(9):1950-1955

Gallinat J, Kunz D, Lang UE, Neu P, Kassim N, Kienast T, Seifert F, Schubert F, Bajbouj M (2007): Association between cerebral glutamate and human behaviour: The sensation seeking personality trait Neuroimage 34: 671-678

Gallinat J, Götz T, Kalus P, Bajbouj M, Sander T, Winterer G (2007): Genetic variations of the NR3A subunit of the NMDA receptor modulate prefrontal cerebral activity in humans. J Cogn Neuroscience 19: 59-68

Gallinat J, Lang UE, Jacobsen LL, Bajbouj M, Kalus P, von Haebler D, Seifert F, Schubert F (2007): Abnormal hippocampal neurochemistry in smokers: Evidence from proton magnetic resonance spectroscopy at 3 tesla. J Clin Psychopharmacol 27(1): 80-84

Gallinat J*, Bajbouj M, Lang UE, Florence H, Vesper J, Lisanby SH, Danker-Hopfe H, Neu P (2007): Motor cortex excitability after vagus nerve stimulation in major depression. J Clin Psychopharmacol 27(2): 156-159 *shared first authorship

Domula M, Schulze D, Felber W, Gallinat J, Lang UE (2007): Cat eye syndrome associated with schizophrenia. Pharmacopsychiatry 40(1):38-39.

Lang UE, Stogowski D, Schulze D, Domula M, Schmidt E, Gallinat J, Tugtekin SM, Felber W (2007): Charles Bonnet Syndrome: Successful treatment of visual hallucinations due to vision loss with selective serotonin reuptake inhibitors J Psychopharmacology 21(5): 553-555

Lohoff FW, Dahl JP, Ferraro TN, Arnold SE, Gallinat J, Sander T, Berrettini WH (2006): Variations in the vesicular monoamine transporter 1 gene (VMAT1/SLC18A1) are associated with bipolar I disorder Neuropsychopharmacology 31(12): 2739-2747

Winterer G, Musso F, Vucurevic G, Stoeter P, Konrad A, Seker B, Gallinat J, Dahmen N, Weinberger DR (2006): COMT-genotype predicts BOLD signal and noise characteristics in prefrontal circuits Neuroimage 32(4): 1722-1732

Gallinat J, Meisenzahl E, Jacobsen, LK, Kalus P, Bierbrauer J, Kienast T, Witthaus H, Leopold K, Seifert F, Schubert F, Staedtgen M (2006): Smoking and structural brain deficits: A volumetric MR investigation. Eur J Neurosci 24: 1744-1750

Gallinat J, Heinz A (2006): Combination of multimodal imaging and molecular genetic information to investigate complex psychiatric disorders. Pharmacopsychiatry 39 (Suppl 1): 76-79

Neuhaus AH, Luborzewski A, Rentzsch J, Brakemeier EL, Opgen-Rhein C, Gallinat J, Bajbouj M (2006) P300 is enhanced in responders to vagus nerve stimulation for treatment of major depressive disorder. J Affect Disord 100(1-3): 123-128

Krystal JH, D'souza DC, Gallinat J, Driesen N, Abi-Dargham A, Petrakis I, Heinz A, Pearlson G (2006): The vulnerability to alcohol and substance abuse in individuals diagnosed with schizophrenia. Neurotox Res 10(3-4): 235-252

Lang UE, Bajbouj M, Gallinat J, Hellweg R (2006): Brain - derived neurotrophic factor serum concentrations in depressive patients during vagus nerve stimulation and repetitive transcranial magnetic stimulation. Psychopharmacology 187(1): 56-59

Neuhaus AH, Bajbouj M, Kienast T, Kalus P, von Haebler D, Winterer G, Gallinat J (2006): Persistent dysfunctional frontal lobe activation in former smokers. Psychopharmacology 186(2): 191-200

Kirchheiner J, Lang UE, Stamm T, Sander T, Gallinat J (2006): Association of CYP2D6 genotypes and personality traits in psychiatric healthy individuals. J Clin Psychopharmacol 26(4): 440-442

Gallinat J (2006): Dysfunctional glutamatergic neurotransmission in schizophrenia. In: Semke VYa, Lanf F (eds.), Pathophysiology of Mental Diseases. Russion Academy of Medical Science, Tomsk: p 64-77

Gallinat J, Kunz D, Senkowski D, Kienast T, Seifert F, Schubert F, Heinz A (2006): Hippocampal glutamate concentration predicts cerebral theta oscillations during cognitive processing. Psychopharmacology 187(1): 103-111

Uhl I, Gorynia I, Gallinat J, Mulert C, Wutzler A, Heinz A, Juckel G (2006): Is the loudness dependence of auditory evoked potentials modulated by the selective serotonin reuptake inhibitor citalopram in healthy subjects? Hum Psychopharmacol 21(7): 463-471

Juckel G, Schlagenhauf F, Koslowski M, Filonov D, Wustenberg T, Villringer A, Knutson B, Kienast T, Gallinat J, Wrase J, Heinz A (2006): Dysfunction of ventral striatal reward prediction in schizophrenic patients treated with typical, not atypical, neuroleptics. Psychopharmacology 187(2): 222-228

Kalus P, Slotboomb J, Gallinat J, Mahlberg R, Cattapan-Ludewigc K, Wiestb R, Nyffelerd T, Buri C, Federspiele A, Kunz D, Schroth G, Kiefer C (2005): Examining the Gateway to the Limbic System with Diffusion Tensor Imaging: The Perforant Pathway in Dementia: Neuroimage 30(3): 713-720

Neuhaus A, Gallinat J, Bajbouj M, Reischies F (2005): Interictal slow-wave focus in left medial temporal lobe during bilateral electroconvulsive therapy. Neuropsychobiology 52: 183-189

Lohoff FW, Sander T, Ferraro TN, Dahl JP, Gallinat J, Berrettini WH (2005): Confirmation of association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) gene and bipolar I disorder. Am J Med Genet B 139(1): 51-53

Gallinat J, Hellweg R, Lang UE (2005): Indicators of central serotonergic activity: How “specific” is neurotransmission? Neuropsychopharmacology 30: 1586-1587

Kalus P, Slotboom J, Gallinat J, Federspiel A, Gralla J, Remonda L, Strik WK, Schroth G, Kiefer C (2005): New evidence for involvement of the entorhinal region in schizophrenia: a combined MRI volumetric and DTI study. Neuroimage 24(4): 1122-1129

Kalus P, Slotboomb J, Gallinat J, Wiest R, Ozdob C, Federspiel A, Strik WK, Schroth G, Kiefer C (2005): The Amygdala in Schizophrenia: A Trimodal Magnetic Resonance Imaging Study. Neurosci Lett 375(3): 151-156

Gallinat J, Kunz D, Lang UE, Kalus P, Juckel G, Eggers J, Mahlberg R, Staedtgen M, Wernicke C, Rommelspacher H, Smolka MN (2005): Serotonergic effects of smoking are independent from the human serotonin transporter gene promoter polymorphism: Evidence from auditory cortical stimulus processing Pharmacopsychiatry 38: 158-160

Lang UE, Hellweg R, Bajbouj M, Lenzen KP, Sander T, Kunz D, Gallinat J (2005): Association of a functional BDNF polymorphism and anxiety-related personality traits Psychopharmacology 180(1): 95-99

Lang UE, Hellweg R, Gallinat J (2005): Association of BDNF serum concentrations with central serotonergic activity: Evidence from auditory signal processing Neuropsychopharmacology 30: 1148-1153

Gallinat J, Ströhle A, Lang UE, Bajbouj M, Kalus P, Montag C, Seifert F, Wernicke C, Rommelspacher H, Rinneberg H, Schubert F (2005): Association of human hippocampal neurochemistry, serotonin transporter genetic variation, and anxiety. Neuroimage 26(1): 123-131

Reischies FM, Neuhaus AH, Hansen ML, Mientus S, Mulert Ch, Gallinat J (2005): Electrophysiological and neuropsychological analysis of a delirious state - the role of the anterior cingulate gyrus Psychiat Res-Neuroimaging 138(2): 171-181

Heinz A, Braus DF, Romero B, Gallinat J, Puls I, Juckel G, Weinberger DR (2004): Genetic and pharmacological effects on prefrontal cortical function in schizophrenia. Nervenarzt 75(9): 845-856

Gallinat J, Montag C, Heinz A (2004): Differentialdiagnosen der Schizophrenie. Psycho Neuro 3: 146-152

Mulert C, Pogarell O, Juckel G, Rujescu D, Giegling I, Rupp D, Mavrogiorgou P, Bussfeld P, Gallinat J, Möller HJ, Hegerl U (2004): The neural basis of the P300 potential: Focus on the time-course of the underlying cortical generators Eur Arch Psychiatry Clin Neurosci 254(3):190-198

Heinz A, Goldman D, Gallinat J, Schumann G, Puls I (2004): Pharmacogenetic insights to monoaminergic dysfunction in alcohol dependence Psychopharmacology 174(4): -570

Lang UE, Hellweg R, Gallinat J (2004): BDNF serum concentrations in healthy humans are associated with depression-related personality traits. Neuropsychopharmacology 29(4): 795-798

Lang UE, Bajbouj M, Wernicke C, Rommelspacher H, Danker-Hopfe H, Gallinat J (2004): No association of a functional polymorphism in the serotonin transporter gene promoter and anxiety-related personality traits. Neuropsychobiology 49(4): 182-184

Gallinat J, Winterer G, Herrmann CS, Senkowski D (2004): Reduced oscillatory gamma-band responses in unmedicated schizophrenic patients indicate impaired frontal network processing Clin Neurophysiology 115(8):1863-1874

Meisenzahl EM, Frodl T, Müller D, Schmitt G, Gallinat J, Zetzsche T, Marcuse A, Juckel G, Leinsinger G, Hahn K, Moller HJ, Hegerl U (2004): Superior temporal gyrus and P300 in schizophrenia: a combined ERP/structural magnetic resonance imaging investigation J Psychiatr Res 38(2): 153-162

Bajbouj M, Gallinat J, Lang U, Röricht S, Meyer BU (2004): Abnormalities of inhibitory neuronal mechanisms in the motor cortex of patients with schizophrenia Pharmacopsychiatry 37(2): 74-80

Schubert F, Gallinat J, Seifert F, Rinneberg H (2004): Glutamate concentrations in the human brain using single voxel proton magnetic resonance spectrscopy at 3 Tesla Neuroimage 24: 1762-1771

Juckel G, Mavrogiorgou P, Bredemeier S, Gallinat J, Frodl T, Schulz C, Möller H-J, Hegerl U (2004): Loudness dependence of primary auditory cortex evoked activity as predictor of therapeutic outcome to prophylactic lithium treatment in affective disorders - A retrospective Study. Pharmacopsychiatry 37(2): 46-51

Bajbouj M, Gallinat J, Lang UE, Neu P, Niehaus L: Motorcortical excitability after electroconvulsive therapy in patients with major depressive disorder (2003): Suppl Clin neurophysiology 56: 433-440

Heinz A, Romero B, Gallinat J, Juckel G, Weinberger DR (2003): Molecular brain imaging and the neurobiology and genetics of schizophrenia. Pharmacopsychiatry 26 Suppl 3: 152-157

Doepp F, Schreiber SJ, Benndorf G, Radtke A, Gallinat J, Valdueza JM (2003): Venous drainage patterns in a case of pseudotumor cerebri following unilateral radical neck dissection. Acta Otolaryngol 123(8): 994-997

Lang U, Gallinat J, Danker-Hopfe H, Bajbouj M, Hellweg R (2003): Nerve growth factor serum concentrations in healthy human volunteers: physiological variance and stability. Neurosci Lett 344(1): 13-16

Wernicke C, Samochowiec J, Schmidt LG, Winterer G, Smolka M, Kucharska-Mazur J, Horodnicki J, Gallinat J, Rommelspacher J (2003): Polymorphisms in the N-Methyl-D-Aspartate receptor 1 and 2b Subunits are associated with alcoholism-related traits Biol Psychiatry 54(9): 922-928

Winterer G, Smolka M, Samochowiec J, Ziller M, Mahlberg R, Gallinat J, Rommelspacher HP, Herrmann, WM, Sander T (2003): Association of EEG coherence and an exonic GABABR1 gene polymorphism. Am J Med Genet 117B(1): 51-56

Gallinat J, Juckel G, Riedel M, Sokullu S, Schulz C, Möller HJ, Müller N, Hegerl U (2003): Serotonergic dysfunction in schizophrenia assessed by the loudness dependence of primary auditory cortex evoked activity. Schizophr Res 64: 115-124 (shared first authorship)

Gallinat J, Bajbouj M, Sander T, Schlattmann P, Xu K, Ferro EF, Goldman D, Winterer G (2003): Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 54(1): 40-48

Mulert C, Gallinat J, Dorn H, Herrmann WM, Winterer G (2003): The relationship between reaction time, error rate and anterior cingulate cortex activity. Int J Psychophysiol 47(2): 175-183

Gallinat J, Stotz-Ingenlath G, Lang UE, Hegerl U (2003): Panic attacks, spike-wave activity, and limbic dysfunction. Pharmacopsychiatry 36(3):123-126

Gallinat J, Senkowski D, Wernicke C, Juckel G, Becker I, Sander T, Smolka M, Hegerl U, Rommelspacher H, Winterer G, Herrmann WM (2003): Allelic variants of the functional promoter polymorphism of the human serotonin transporter gene is associated with auditory cortical stimulus processing. Neuropsychopharmacology 28(3): 530-532

Senkowski D, Linden M, Zubrägel D, Bär T, Gallinat J (2003): Evidence for disturbed cortical signal processing and altered serotonergic neurotransmission in generalized anxiety disorder Biol Psychiatry 53(4): 304-314

Hegerl U, Mergl R, Henkel V, Gallinat J, Kotter G, Müller-Siecheneder F, Pogarell O, Juckel G, Schröter A, Bahra R, Emir B, Laux G, Möller HJ (2003): Kinematic analysis of the effects of donepezil hydrochloride on hand motor function in patients with alzheimer dementia. J Clin Psychopharmacol 23(2): 214-216

Mavrogiorgou P, Juckel G, Frodl T, Gallinat J, Hauke W, Zaudig M, Dammann G, Möller HJ, Hegerl U (2002): P300 subcomponents in obsessive-compulsive disorder. J Psychiatr Res 36(6): 399-406

Gallinat J, Mulert C, Bajbouj M, Herrmann WM, Schunter J, Senkowski D, Muchtieva R, Kronfeldt D, Winterer G (2002): Frontal and temporal dysfunction of auditory stimulus processing in schizophrenia. Neuroimage 17: 110-127

Wernicke C, Smolka M, Gallinat J, Winterer G, Schmidt LG, Rommelspacher H (2002): Evidence for the importance of the human dopamine transporter gene for withdrawal symptomatology of alcoholics in a German population. Neurosci Lett 333(1): 45-48

Neukirch M, Hegerl U, Kötitz R, Dorn H, Gallinat J, Herrmann WM (2002): Comparison of the amplitude/intensity function of the auditory evoked N1m and N1 components. Neuropsychobiology 45(1): 41-8

Mientus S, Gallinat J, Wuebben Y, Pascual-Marqui RD, Mulert C, Frick K, Dorn H, Herrmann WM, Winterer G (2002): Cortical hypoactivation during resting EEG in schizophrenics but not in depressives and schizotypal subjects as revealed by Low Resolution Electromagnetic Tomography (LORETA). Psych Res: Neuroimaging 116: 95-111

Lang UE, Gallinat J, Kuhn S, Jockers-Scherübl MC, Hellweg R (2002): Nerve Growth Factor and Smoking Cessation. Am J Psychiatry 159(4): 674-675

Schlattmann P, Gallinat J, Böhning D (2001): Spatio-temporal partition modeling: An example from neurophysiology In: Spatial cluster modelling, Lawson AB, Denison D (eds.). Chapman & Hall, Boca Raton: p 227-234

Winterer G, Mulert C, Mientus S, Gallinat J, Schlattmann P, Dorn H, Herrmann WM (2001): P300 and LORETA: comparison of normal subjects and schizophrenic patients. Brain Topogr 13: 299-313

Gallinat J, Riedel M, Juckel G, Sokullu S, Frodl T, Moukhtieva R, Mavrogiorgou P, Nisslé S, Müller N, Danker-Hopfe H, Hegerl H (2001): P300 and symptom improvement in schizophrenia. Psychopharmacology 158: 55-65

Mulert C, Gallinat J, Pascual-Marqui R, Dorn H, Frick K, Schlattmann P, Mientus S, Herrmann WM, Winterer G (2001): Reduced Event-Related Current Density in the Anterior Cingulate Cortex in Schizophrenia. Neuroimage 13: 589-600

Hegerl U, Gallinat J, Juckel G (2001): Event-related potentials. Do they reflect central serotonergic neurotransmission and do they predict clinical response to serotonin agonists? J Affect Disord 62: 93-100

Winterer G, Smolka M, Samochowiec J, Mulert C, Ziller M, Mahlberg R, Wuebben Y, Gallinat J, Rommelspacher H, Herrmann WM, Sander T (2000): Association analysis of GABAa beta2 and gamma2 gene polymorphisms with event-related prefrontal activity in man. Hum Genet 107: 513-518

Frodl T, Juckel G, Gallinat J, Bottlender R, Riedel M, Preuss U, Möller HJ, Hegerl U (2000): Dipole localization of P300 and normal aging. Brain Topogr 13(1): 3-9

Gallinat J, Boetsch T, Padberg F, Hampel H, Herrmann WM, Hegerl U (2000): Is the EEG helpful in diagnosing and monitoring lithium intoxication? A case report and review of the literature. Pharmacopsychiatry 33(5): 169-173

Juckel G, Hegerl U, Mavrogiorgou P, Gallinat J, Mager T, Tigges P, Dresel S, Schroter A, Stotz G, Meller I, Greil W, Möller HJ (2000): Clinical and biological findings in a case with 48-hour bipolar ultrarapid cycling before and during valproate treatment. J Clin Psychiatry 61(8): 585-593

Gallinat J, Bottlender R, Juckel G, Munke-Puchner A, Stotz G, Kuss HJ, Mavrogiorgou P, Hegerl U (2000): The loudness dependency of the auditory evoked N1/P2-component as a predictor of the acute SSRI response in depression. Psychopharmacology 148: 404-411

Tigges P, Mergl R, Frodl T, Meisenzahl EM, Gallinat J, Schröter A, Riedel M, Müller N, Möller HJ, Hegerl U (2000): Digitized analysis of abnormal hand-motor performance in schizophrenic patients. Schizophr Res 45: 133-143

Carrillo-de-la-Pena MT, Mavrogiorgou P, Juckel G, Hauke W, Gallinat J, Frodl T, Zaudig M, Hegerl U (2000): Loudness dependence of auditory evoked potentials in obsessive-compulsive disorder: a pilot study. Psychiatry Res 93: 209-216

Grunze H, Gallinat J, Haag C, Hegerl U (2000): Psychopathological and auditory evoked potential correlates of ketamine psychosis--a single case report. Schizophr Res 21: 386-388

Gallinat J, Möller HJ, Moser RL, Hegerl U (1999): Das postoperative Delir: Risikofaktoren, Prophylaxe und Therapie. Der Anaesthesist 48: 507-518

Frodl-Bauch T, Gallinat J, Meisenzahl EM, Möller HJ, Hegerl U (1999): P300 subcomponents reflect different aspects of psychopathology in schizophrenia. Biol Psychiatry 45(1): 116-126

Gallinat J, Möller HJ, Hegerl U (1999): Piracetam in der Anästhesie zur Prophylaxe eines postoperativen Delirs. Anasth Intensiv Notf 34: 520-527

Gallinat J, Hegerl U (1999): Gesteigerte limbische Erregungsbildung bei Angstattacken. Der Nervenarzt 70: 206-215

Frodl T, Meisenzahl EM, Gallinat J, Hegerl U, Möller HJ (1998): Markers from event related-potential subcomponents and reaction time for information processing dysfunction in schizophrenia. Eur Arch Psychiatry Clin Neurosci 248: 307-313

Möller HJ, Gallinat J, Hegerl U, Arato M, Janka Z, Pflug B, Bauer H (1998): Double-blind, multicenter comparative study of sertraline and amitriptyline in hospitalized patients with major depression. Pharmacopsychiat 31: 170-177

Hegerl U, Bottlender R, Gallinat J, Kuss H-J, Ackenheil M, Möller H-J (1998): The Serotonin Syndrome Scale: First results on validity. Eur Arch Psychiatry Clin Neurosci 248(2): 96-103

Gallinat J, Hegerl U (1998): Elektroenzephalographie. In: Hegerl U, (ed.) Neurophysiologische Untersuchungsmethoden in der Psychiatrie, Springer, Wien: p 7-94

Hegerl U, Juckel G, Gallinat J, Möller HJ (1997): Event-related potentials as indicators of serotonergic dysfunction. Intern Psychiatry Today 7: 7-9

Kathmann N, Soyka M, Gallinat J, Hegerl U (1995): Effects of acamprosate on verbal learning in healthy young subjects. In: Soyka M (ed.) Acamprosate, Springer, Berlin: p 105-110

Hegerl U, Gallinat J, Mrowinski D (1995): Sensory cortical processing and the biological basis of personality. Biol Psychiatry 37: 467-472

Hegerl U, Soyka M, Gallinat J, Ufer S, Preuß U, Bottlender R, Möller HJ (1995): Event-related potentials and EEG as indicators of central neurophysiological effects of acamprosate. In: Soyka M (ed.) Acamprosate, Springer, Berlin: p 93-104

Hegerl U, Juckel G, Gallinat J, Schmidt L (1995): Akustisch evozierte Dipolquellen bei Alkoholabhängigkeit: Ein Indikator serotonerger Dysfunktion? In: Peters UH, Schifferdecker M, Krahl A (eds.), 150 Jahre Psychiatrie. Martini-Verlag, Köln: p 340-342

Juckel G, Frota A, Gallinat J, Schmidt L, Rommelspacher H, Hegerl U (1994): Auditory-evoked dipole sources activity as indicator of withdrawal severity in alcoholic patients. Pharmacopsychiatry 27: 79-81

Hegerl U, Gallinat J, Mrowinski D (1994): Intensity dependence of auditory evoked dipole source activity. Int J Psychophysiol 17: 1-13